The existence of P2-purinoceptors in the cere brovascular bed was examined by testing the effects of ATP and its stable analog, u,p-methylene-ATP, on CBF in the unanesthetized goat as well as on isometric tension in isolated goat middle cerebral artery. When injected directly into the cerebral circulation, A TP increased and u,p-methylene-ATP decreased CBF. Indomethacin did not modify either of these effects. The vasoconstrictor action of u,p-methylene-ATP was reduced by nicar dipine. "In vitro," both ATP and u,p-methylene-ATP contracted the cerebral arteries at resting tone, but the analog was more potent than A TP. Repeated application of u,p-methylene-ATP as well as indomethacin signifi-Since the initial classification of purinergic recep tors into types PI and P2 (Burnstock, 1978), several subtypes have been proposed. With regard to the P2-purinoceptors, two subtypes can be distin guished: P2x and P2y' This is the conclusion reached in biochemical and pharmacological studies in which the relative potency of a series of synthetic analogs of ATP is determined. For the P2x receptor, the order of potency is u,�-methylene-ATP, �,'Y-methylene ATP > ATP = 2-methylthio-ATP. For the P2y receptor, the order of potency is 2methylthio-ATP }> ATP > u,�-methylene-ATP, �,'Y-methylene-ATP. While activation of P2x recep tors leads to excitatory responses, activation of P2y leads to inhibitory responses (Burnstock and Kennedy, 1985a).
cantly reduced the ATP-induced contractions. Nicar dipine inhibited both the u,p-methylene-ATP-and the ATP-induced contractile response. In preconstricted ar teries, ATP produced relaxation and u,p-methylene-ATP induced further contraction. The relaxant response to ATP was not modified by indomethacin. These results show the existence of two subtypes of P2-purinoceptors in brain circulation: P2x, more sensitive to u,P methylene-ATP than to ATP, which elicits cerebral vas oconstriction; and P2y, sensitive to ATP, which elicits cerebral vasodilation. Key Words: Cerebral arteries-P2x receptors-P 2y receptors-ATP-u,p-methylene-ATP. nism of the P 2-purinoceptors has become elusive as a consequence of the lack of specific antagonists. It has been stated that following administration of u,�-methylene-ATP, P2x receptors can be desensi tized, but P2y receptors cannot be, thus providing a simple method for characterizing the P2x-mediated responses to ATP (Kasakov and Burnstock, 1983; Burnstock and Kennedy, 1985a) . However, some experimental findings indicate that u,�-methy lene-ATP does not desensitize ATP in a variety of tissues such as guinea pig taenia caeci (Den Hertog et aI., 1985) and ileum (Wiklund and Gustafsson, 1988) . Therefore, a third subtype of Pz-purinoceptor (P2s) with moderate desensitization by u,�-methy lene derivatives has been proposed (Wiklund and Gustafsson, 1988) .
In a previous work, we demonstrated the exist ence of PI-purinoceptors in the cerebral circulation by using an experimental model "in vivo" (Torre grosa et aI., 1988). The present work was designed to investigate the existence of P2-purinoceptors in the cerebrovascular bed of the goat, "in vivo" and "in vitro." For this purpose, the effects of ATP and its stable analog, u,�-methylene-ATP, on CBF in the unanesthetized goat, as well as on isometric ten sion in isolated goat cerebral arteries, were ana-lyzed. The ability of a,J3-methylene-ATP to abolish the ATP-induced response was also examined. In addition, the possible relationship between P2purinoceptors and prostaglandins was studied by testing the effects of both agonists in the presence of indomethacin.
MATERIALS AND METHODS
"In vivo" experiments: measurement of CBF
Experimental procedure
Female goats weighing 30 to 40 kg were used in this study. The goat was selected because its unique arterial supply to the brain permits the measurement of the entire hemispheric blood flow (CBF). The operative procedure for measuring CBF has been described previously (Rei mann et al., 1972) . Briefly, after sedation with 10 mg/kg of ketamine (Ketolar, Parke-Davis, intramuscular), the sa phenous vein was cannulated to give a slow infusion of 2% sodium thiopental (Sodium Pentothal, Abbott). Under gastric and tracheal intubation, anesthesia was main tained by means of a ventilator (ATM Logic 03A) supply ing 1.5% halothane (Fluothane, ICI) in oxygen. An inci sion was made along the left mandible, and a small por tion of the mandible was removed to expose the internal maxillary, ramus anastomoticus, temporal, and dental ar teries. Ligatures were placed on the internal maxillary distal to the ramus anastomoticus and on the dental ar teries. Because of the physical inaccessibility of ophthal mic, ethmoidal, and buccinator arteries, blood flow through them was eliminated by thrombosing them with a slow injection of 1,000 NIH units of thrombin (Thrombin, topical, Parke-Davis) in 0.5 ml of saline into the internal maxillary artery distal to the site of ligation. This maneu ver produced immediate obliteration of these extracere bral vessels, evidenced by the appearance of thrombosed vessels in the sclera and postsurgical blindness. In these conditions, virtually all of the blood flow from the internal maxillary artery is destined for the brain (Miletich et aI., 1975) . Therefore, an electromagnetic flow probe around the internal maxillary artery accurately measures the blood flow to the ipsilateral hemisphere. A catheter was introduced into the temporal artery and permanently fixed to permit injection or infusion of drugs into the in ternal maxillary artery. A snare-type occluder was placed on the external carotid artery, close to the temporal ar tery, to obtain zero-flow baselines. The external connect ing leads from the flow probe, temporal artery catheter, and occluder were led out subcutaneously and secured to the goat's horn. A catheter was inserted into the femoral artery and permanently fixed to measure the MABP. CBF was measured by connecting the electromagnetic flow probe (Carolina Medical Electronics) placed around the internal maxillary artery, to an electromagnetic flow meter (Carolina Medical Electronics, model 501D). The MABP was obtained by connecting the femoral artery catheter to a Hewlett Packard transducer (model 1280C). Heart rate (HR) was measured from the CBF or arterial blood pressure (ABP) pulse with a Hewlett Packard rate meter (model 7807C). CBF (pulsatile and mean), MABP, and HR were continuously registered with a Hewlett Packard recorder (model 7758A). Cerebral vascular resis tance (CVR) was calculated as the MABP in mm Hg di-vided by CBF in m1lmin/100 g of tissue. After termination of the experiments, the animals were killed by intrave nous injection of 30 mEq of potassium chloride, and the whole brain was removed from the skull and weighed for accurate calculation of CBF in m 1l min/100 g o f tissue.
Experiments were performed in the conscious animal, and started 3-5 days after surgery, at which time the goats were fully recovered and in a steady cardiorespiratory state. The various measurements were taken with the goat in a large cage without restraints, except f or a Lucite stock fitting loosely around the neck, which limited for ward and backward motion. Once placed in the cage, the animal stood quietly during the experiments and showed no signs of any disturbance.
Drugs employed as P2-purinoceptor agonists in this study were ATP and a,�-methylene-ATP. Their effects were evaluated by injecting increasing doses (1, 3, 10, 30, and 100 Il-g) into the internal maxillary artery. The drugs were injected through the temporal catheter in a volume of 1 ml of saline solution and the catheter was then im mediately washed out with an additional 1 ml of the same saline solution. Control injections of saline solution never produced any artifact or subsequent change in CBF.
To determine the possible involvement of the mecha nisms that mediate cerebral vasoconstriction in the goat in the response to a,j3-methylene-ATP, its effects on CBF were evaluated before and during the following treat ments: blockade of a-adrenoceptors with phentolamine (1-2 mg intra-arterial), blockade of neuronal uptake with cocaine (1-2 mg intra-arterial) (Lluch et aI., 1975) , and blockade of tryptaminergic receptors with methysergide (100 Il-g/min intra-arterial) (Dieguez et aI., 1981) . The pos sibility that a calcium-related phenomenon could be in volved in the response to a,j3-methylene-ATP was exam ined by assessing its effects on CBF before and during infusion of the calcium entry blocker, nicardipine (100 Il-g/min intra-arterial).
The possible relationship between the activation of P2purinoceptors and the stimulation of prostaglandin bio synthesis was examined by analyzing the effects of ATP and a,�-methylene-ATP on CBF, be f ore and during treat ment with the inhibitor of prostaglandin biosynthesis, in domethacin (5 mg/kg intraperitoneal). It has been re ported that treatment with a similar dose inhibits prosta glandin biosynthesis in rat brain and blood vessels by 80% (Abdel-Halim et aI., 1978) .
Analysis of the results
For experiments with agonists alone, three to four in jections of each dose, starting from the lowest (1 Il-g), were administered. This experiment was repeated two to three times on different days in each goat, and the results were then averaged to obtain one value for each dose. From all of the individual data, the mean, SD, and SEM were calculated. In the experiments in which a treatment was established, the experimental protocol was as fol lows: four to six injections of a given dose of the agonist to be tested were administered before and during each treatment. This experiment was repeated two to three times on different days in each goat, and the results were then averaged to obtain one value for the "control effect" (i.e., before treatment) and one for the "experimental effect" (i.e., during treatment). From these values for all of the goats, the mean, SD, and SEM were then calcu lated. The control and experimental data were compared statistically by means of the paired Student's t-test; a probability value of less than 5% is considered to be sig nificant.
Drugs and solutions
The following drugs were used: ATP, a,ll-methylene ATP, and indomethacin (all from Sigma), phentolamine (Regitine, Ciba) , cocaine (chloride, Abello), nicardipine (Ferrer Internacional), and methysergide (Sandoz). All solutions were made up in distilled water, and further dilutions were obtained in saline solution up to the re quired concentration. Indomethacin was dissolved in eth anol (10 mg/ml) and diluted in a physiological solution (2 mg/ml) of the following composition (mM): NaCI, 120; KCI, 5.4; MgCl2 . 7H20, 1.0; NaHC03, 25; and glucose, 5.6, pH 7.3-7.4.
"In vitro" experiments: recording of isometric tension

Experimental procedure
Female goats (30-40 kg), previously anesthetized with intravenous 2% sodium thiopental, were killed by intra venous injection of 30 mEq of potassium chloride. The whole brain was rapidly removed and the middle cerebral arteries were dissected free and cut into cylindrical seg ments 4 mm in length. Each segment was set up in a 5-ml organ bath, and two L-shaped stainless steel pins were introduced through the arterial lumen. One pin was fixed to the organ bath wall, while the other was connected to a strain gauge for isometric tension recording. The vas cular preparations were maintained at 37°C in a physio logical salt solution gassed with 95% O2 and 5% CO2 to give a pH of 7.3-7.4. A resting tension of I g was applied to the arterial segments and they were allowed to equili brate during a period of 60-90 min. Tension was read justed when necessary and the bath fluid was changed every 15 min.
Responses to ATP and a,ll-methylene-ATP were ob tained in a cumulative manner at either resting or precon tractile tone (prostaglandin F2,., 10-5 M). Because both agonists elicited the same response (constrictor) at resting tone, the "desensitization method" was applied under resting conditions. Tachyphylaxis to a,ll-methylene-ATP was produced by adding concentrations of 10 -5 M at 5min intervals without washout in between. The response to this drug completely disappeared after two to three applications (complete desensitization), and the response to ATP was tested in this situation. The responses to ATP and a,ll-methylene-ATP at resting tone were also exam ined during the following treatments: with phentolamine (10-6 M), cocaine (10-6 M), methysergide (10-4 M), nicardipine (10-5 M), and indomethacin (10-5 M). On the other hand, the response to ATP in precontracted arteries was studied during treatment with indomethacin (10 -7, 10-6 M).
Analysis of the results
The tension values were expressed either as a percent age of the response reached with the highest dose (non pre constricted arteries) or as a percentage of prostaglan din F2,. contraction (preconstricted arteries). For each concentration-response curve, the concentration of ago nist that produced one-half of the maximum effect (EC 5 0) was calculated. Mean EC 5 0 and its confidence limits (95% interval) were calculated by obtaining the mean and con fidence limits of the pD2 values ( -log EC 5 0), since they J Cereb Blood Flow Metab, Vol. 10, No.4, 1990 fit tight to a normal distribution. ECso for ATP in nonpre constricted arteries was not calculated because the max imum response could not be reached at the highest dose (10-3 M).
Statistical analysis of the differences between "control" and "experimental" concentration-response curves was done by means of the paired Student's t test applied to pD2 and maximum effect values. A probability value of less than 5% was considered to be significant.
Drugs and solutions
The composition of the physiological salt solution was as follows (mM): NaCI, 120; KCl, 5.4; CaCl2 . 2H20, 2.2; MgCl2 . 7H20, 1.0; NaHC0 3 , 25; and glucose, 5.6. Drugs used were the same as in "in vivo" experiments plus prostaglandin F2,. (Sigma), and they were prepared as explained above to obtain stock solutions of 10-2 M.
Prostaglandin F2,. was dissolved in 95% ethanol. The vol ume of any added drug was 10% of the total bath medium.
RESULTS
"In vivo"
Injections of increasing doses of ATP (1, 3, 10, 30, and 100 tJ. creased HR by 18. 2 ± 5. 0% (p < 0. 05), and in creased CVR by 57. 0 ± 6. 2% (p < 0. 05). Under these experimental conditions, the vasodilatory ac tion of ATP was unchanged with respect to the con trol situation in absolute terms, but it was signifi cantly increased when expressed as a percentage (Table 1) .
The vasoconstrictor response to a,r3-methylene ATP was not altered during treatment with cocaine, indomethacin, phentolamine, and methysergide, but it was significantly reduced during continuous infusion of nicardipine (Fig. 2) .
"In vitro"
At resting tension, ATP 00-6 -10-3 M) and a,r3-methylene-ATP 00-8 -10-5 M) elicited con centration-dependent contractions when added cu mulatively (see Fig. 5 ). EC 5 0 values for a,r3-methy lene-ATP were about 3 x 10-7 M (see Table 2 ), and the maximum response was obtained at 10-5 M.
ATP was less potent than the analog because the concentration-response curve for the former was to the right of that of a,r3-methylene-ATP; however, the relative potency of the two agonists could not be estimated since the EC 5 0 for ATP could not be cal culated.
When the arteries were preconstricted, ATP (10-8 _10-4 M) produced relaxation in a concentra tion-dependent manner, although transient initial contractions were seen for all doses from 10-5 M (Fig. 3) . On the other hand, cumulative addition of a,r3-methylene-ATP 00-9 -10-5 M) produced con centration-dependent contractions (Fig. 3 ). EC 5 0 values for ATP and a,r3-methylene-ATP were 1. 84
(1.38-2.57) x 10-6 M (n = 37) and 1. 28 (0.93-1.69)
x 10-7 M (n = 12), respectively.
At resting tone, neither phentolamine nor cocaine modified the contractile response to ATP. Indo methacin produced a rightward shift in the concen tration-response curve to ATP (Fig. 4 ). The con tractile response to the highest dose of ATP (10-3 M) was reduced by 31. 0 ± 5. 1% (p < 0. 05, n = 10).
After complete tachyphylaxis to a,r3-methylene ATP, the concentration-response curve to A TP was displaced to the right (Fig. 4) , and the contrac tile response to 10 -3 M ATP was reduced by 31. 9 ± 8. 7% (p < 0. 05, n = 12). Nicardipine also shifted the concentration-response curve to ATP to the right (Fig. 5) , and reduced the contractile response to 10-3 M ATP by 49. 7 ± 7. 9% (p < 0. 01, n = 10).
The effects of the different treatments on the con tractile response to a,r3-methylene-ATP in the ce rebral arteries at resting tone are shown in Table 2 .
Only the calcium entry blocker, nicardipine, pro 
DISCUSSION
The present study demonstrates that ATP and its stable analog, a,r3-methylene-ATP, elicit opposite effects on CBF in the unanesthetized goat. The va sodilatory properties of ATP in the cerebral circu lation when administered intravascularly have been confirmed by many studies (Kozniewska et aI. , 1975; Forrester et aI. , 1979; Alborch and Martin, 1979; Torregrosa et aI. , 1988) , but there are no pre vious reports on the "in vivo" effects of a,r3-methy lene-ATP. However, the vasoconstrictor action of this compound in the cerebral circulation is consis tent with the pressor response recorded during its intravascular administration in rats Bulloch and McGrath, 1988) and cats (Ribeiro and Lima, 1985) .
It has been speculated for some time that the ef fect of ATP could be partially due to the adenosine yielded after its breakdown. Two main experimen tal protocols have been followed to examine this possibility: (a) testing of the ability of adenosine antagonists to inhibit the response to ATP; and (b) analysis of the responses to the slowly degradable analog of ATP, a,l3-methylene-ATP. With respect to the former, it has been demonstrated that in the isolated rabbit central ear artery, the endothelium dependent relaxation response to ATP is antago nized by 8-phenyltheophylline. Therefore, an indi rect action of ATP on P1-purinoceptors through the release of adenosine can be suggested . In a previous study (Torre grosa et al. , 1988) , we demonstrated that such an indirect action also takes place in the cerebral cir With respect to the use of a,l3-methylene-ATP, it has been assumed that whenever it mimics the ef fects of A TP, these should be imputable to A TP itself. If opposite effects are found, those of ATP are probably attributable to one of its metabolites, probably adenosine (Ribeiro and Lima, 1985) . In view of the results reported here, one might suggest that ATP acts on the cerebral circulation of the goat mainly through breakdown to adenosine, since a,l3-methylene-ATP and ATP elicited opposite ac tions on CBF. However, on the basis of our own results (Torregrosa et al. , 1988) , it seems more likely that a,l3-methylene-ATP has a specific action that is different from that of A TP, a suggestion pre- viously made by other investigators (Den Hertog et aI. , 1985; Ribeiro and Lima, 1985; Wiklund and Gustafsson, 1988) .
The results obtained "in vitro" showed that at resting tension, both ATP and a,!3-methylene-ATP produced contractions, and that the analog was more potent than A TP. In preconstricted arteries, ATP produced either relaxations (lower concentra tions) or relaxations preceded by transient contrac tions (higher concentrations), while a,!3-methylene ATP produced contractions. These results strongly resemble those previously obtained in the isolated rat femoral artery (Kennedy et aI. , 1985) . They are, however, in disagreement with those obtained in cerebral arteries in rabbits, cats, and humans, which show that a,!3-methylene-ATP relaxes the preconstricted cerebral arteries and that it is more potent than ATP. However, a prominent transient contraction was also seen with both drugs, and once again the analog was more potent than ATP (Hard ebo et aI. , 1987).
According to the criteria for classifying Pzpurinoceptors (Bumstock and Kennedy, 1985a) , it can be concluded that the cerebral arteries are equipped with two subtypes: PZx, more sensitive to a,!3-methylene-ATP than to ATP, the activation of which leads to vasoconstriction; and PZy, sensitive to ATP, the activation of which leads to vasodila tion. The existence of both subtypes could there fore explain the dual response to ATP recorded "in vitro," similar to that described in other vascular beds (Kennedy et aI. , 1985) . 1985b), the vasodilatory action of intravascular ATP could be explained by its interaction with en dothelial P2y receptors. ATP could, in this case, in crease CBF without crossing the blood-brain bar rier (Cornford and Oldendorf, 1975) .
As is generally recognized, selective P2-purino ceptor antagonists do not exist. The method for de sensitizing P2-purinoceptors with a, j3-methy lene-ATP has become widely accepted in recent years, and lends support to the hypothesis that ATP acts as a cotransmitter along with norepinephrine in several vascular tissues (Kennedy et al., 1986; War land and Burnstock, 1987; Machaly et al., 1988) .
The results obtained in the present work showed that a,j3-methylene-ATP significantly inhibited but did not completely abolish the ATP-induced con tractile response. Therefore, it seems evident that at least part of the contractile response to A TP takes place through activation of P2x-purinoceptors, which confirms the conclusion that arises from the studies on agonist potency. However, an important part of this contractile response remains to be ex plained. One possible explanation is that the ATP breakdown products contribute to the effects of ATP. A more speculative possibility is the exist ence of a novel P2-purinoceptor. It was recently proposed that a third subtype (P2s-purinoceptor), which shows no cross-desensitization between A TP and a,j3-methylene-ATP, exists in the guinea pig ileum (Wiklund and Gustafsson, 1988) . Finally, al ternative mechanisms such as nonreceptor actions of the agonists, as pointed out by Wiklund and Gustafsson (1988) , cannot be disregarded. What ever the mechanism may be, these results support the suggestion that ATP and a,j3-methylene-ATP could exert, at least in part, their actions at different sites.
Since the first observation by Needleman and co workers (1974) that ADP and ATP stimulate the re lease of prostaglandins in several organs, while adenosine and AMP do not, the relationship be tween P2-purinoceptors and prostaglandins has been confirmed in many studies (see Burnstock and Brown, 1981) . With respect to the blood vessels, it has been proposed that ATP exerts at least two ac tions on endothelial cells: it induces the release of endothelium-derived relaxing factor(s), and of pros tacyclin (PGI2), an action that seems to be mediated by P2y receptors (Boeynaems et al., 1988) . ethacin on cerebral vessels and the involvement of vasodilatory prostaglandins (PGI2) in the regulation of cerebrovascular tone, as previously proposed (Pickard, 198 1) .
The relaxation response to ATP seen "in vivo"
and "in vitro" did not diminish in the presence of indomethacin. This indicates that stimulation of the production of vasodilatory prostaglandins is not a mechanism that mediates such a response. A simi lar conclusion has been reached in cerebral arteries in rabbits, cats, and humans (Hardebo et al., 1987) .
On the other hand, indomethacin inhibited signifi cantly the contractile response to ATP but not to a,j3-methylene-ATP. This finding confirms the statement that structural conformation of the poly phosphate chain of the ATP molecule is critical for its promotion of prostaglandin biosynthesis , and supports the suggestion that vasoconstrictor prostaglandins could mediate, at least in part, the ATP-induced contractile re sponse in the cerebral arteries. Moreover, this ob servation constitutes another argument in favor of distinct mechanisms of action of ATP and a,j3methylene-ATP.
Our results show that the mechanism of action underlying the contractile action of ATP ("in vitro") and a,j3-methylene-ATP ("in vivo" and "in vitro" ) does not involve activation of a-adreno ceptors, because phentolamine did not alter their effects. ATP must not be considered as an indirect sympathomimetic drug, because cocaine did not modify its vasoconstrictor action; on the contrary, such a mechanism of action should not be disre garded for a,j3-methylene-ATP. Activation of tryptaminergic receptors must also be disregarded in the case of a,j3-methylene-ATP, because methy sergide had no effect on its contractile response.
The fact that the calcium entry blocker, nicardipine, was able to inhibit both a,j3-methylene-ATP-and ATP-induced cerebral vasoconstriction indicates that influx of extracellular Ca 2 + into the smooth muscle cells of the cerebral arteries is needed for there to be a contractile response to both drugs.
In summary, we present experimental evidence obtained "in vivo" and "in vitro" that shows the existence of P2-purinoceptors in the cerebral arter ies of the goat. On the basis of the opposite effects of ATP (predominantly relaxant) and a,j3-methy lene-ATP (constrictor), two subtypes can be sug gested to exist: P2x receptors, which mediate a,j3-methylene-ATP-and, to a lesser extent, ATP induced cerebral vasoconstriction; and P2y recep tors, which mediate ATP-induced cerebral vasodi lation. Prostaglandins are not involved in the latter effect. Although both ATP and a,j3-methylene-ATP produced contractions "in vitro," their effects do not seem to be mediated by the same mechanism: u,!3-methylene-ATP does not completely abolish the contractile response to ATP, and indomethacin partially blocks ATP-but not u,!3-methylene ATP-induced contractile responses. However, the contractile responses to both drugs show a similar dependence on extracellular Ca 2 + .
